MYB deregulation is also associated with colorectal cancers [7,8], carcinomas [9] and breast cancers expressing oestrogen receptor-alpha [10], in which MYB has been implicated in prolactin-induced signalling pathways [11]. The gene discussed is MYB; the disease is breast carcinoma.